Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
A25022 IPKine™ HRP, Mouse Anti-Rabbit IgG LCS Disruption of Ssp411 causes impaired sperm head formation and male sterility in mice(A25022-2) 2 Biochim Biophys Acta
BMS0140 Normal Donkey Serum Disruption of the Na+/K+-ATPase-purinergic P2X7 receptor complex in microglia promotes stress-induced anxiety(BMS0140-26.3) 26.3 PLoS One
A21110 AP, Goat Anti-Mouse IgG Dissecting the Arginine and Lysine Biosynthetic Pathways and Their Relationship in Haloarchaeon Natrinema gari J7-2 via Endogenous CRISPR-Cas System-Based …(A21110-4) 4 Microbiology Spectrum
BMU106 Dissecting the Implications of Calumenin in Malignancy and Heterogeneity of the Microenvironment of Clear Cell Renal Cell Carcinoma Using Multi-Omics Data.(BMU106-4) 4 Phenomics
KTP3007 ExKine™ Pro Total Protein Extraction Kit for Animal Cultured Cells/Tissues Dissecting the Implications of Calumenin in Malignancy and Heterogeneity of the Microenvironment of Clear Cell Renal Cell Carcinoma Using Multi-Omics Data.(KTP3007-4) 4 Phenomics
A01020 Distribution and Dynamic Changes in Matrix Metalloproteinase (MMP)-2, MMP-9, and Collagen in an In Stent Restenosis Process(A01020-5) 5 Eur J Vasc Endovasc Surg
A23210 DyLight 488, Goat Anti-Mouse IgG Disulfiram improves fat graft retention by modulating macrophage polarization with inhibition of NLRP3 inflammasome-mediated pyroptosis(A23210-3.9) 3.9 Microbial Pathogenesis
A23420 Dylight 594, Goat Anti-Rabbit IgG Disulfiram improves fat graft retention by modulating macrophage polarization with inhibition of NLRP3 inflammasome-mediated pyroptosis(A23420-3.9) 3.9 Front Pharmacol
A23220 Dylight 488, Goat Anti-Rabbit IgG Disulfiram suppresses epithelial-mesenchymal transition (EMT), migration and invasion in cervical cancer through the HSP90A/NDRG1 pathway(A23220-5) 5 Cellular Signalling
KTB1100 CheKine™ Micro Lactate Assay Kit Divalent metal ions enhance bone regeneration through modulation of nervous systems and metabolic pathways.(KTB1100-20.3) 20.3  Bioactive Materials